{
      "Rank": 4,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "A single dose of 500\u3395/\u33a0 of cartilage defect",
            "conventional treatment method"
      ],
      "ArmGroupInterventionName": [
            "Biological: CARTISTEM",
            "Procedure: Microfracture"
      ],
      "ArmGroupLabel": [
            "CARTISTEM",
            "Microfracture"
      ],
      "ArmGroupType": [
            "Experimental",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01626677"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This is a long term follow-up study to investigate the safety and efficacy of CARTISTEM\u00ae, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture. Subjects who participated in and completed the Phase III trial (NCT01041001) will be tracked until the 60 month post-treatment timepoint."
      ],
      "BriefTitle": [
            "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [
            "INDUSTRY"
      ],
      "CollaboratorName": [
            "Dong-A Pharmaceutical Co., Ltd."
      ],
      "CompletionDate": [
            "May 2015"
      ],
      "CompletionDateType": [
            "Actual"
      ],
      "Condition": [
            "Degenerative Osteoarthritis",
            "Defect of Articular Cartilage"
      ],
      "ConditionAncestorId": [
            "D000001168",
            "D000007592",
            "D000009140",
            "D000012216",
            "D000050723",
            "D000014947"
      ],
      "ConditionAncestorTerm": [
            "Arthritis",
            "Joint Diseases",
            "Musculoskeletal Diseases",
            "Rheumatic Diseases",
            "Fractures, Bone",
            "Wounds and Injuries"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC05",
            "All",
            "BC26",
            "BC17"
      ],
      "ConditionBrowseBranchName": [
            "Musculoskeletal Diseases",
            "All Conditions",
            "Wounds and Injuries",
            "Skin and Connective Tissue Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Osteoarthritis",
            "Microfracture"
      ],
      "ConditionBrowseLeafId": [
            "M12078",
            "M25523",
            "M17484",
            "M3628",
            "M9773",
            "M11249",
            "M14197",
            "M5475",
            "M16837"
      ],
      "ConditionBrowseLeafName": [
            "Osteoarthritis",
            "Fractures, Bone",
            "Fractures, Stress",
            "Arthritis",
            "Joint Diseases",
            "Musculoskeletal Diseases",
            "Rheumatic Diseases",
            "Collagen Diseases",
            "Wounds and Injuries"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000010003",
            "D000015775"
      ],
      "ConditionMeshTerm": [
            "Osteoarthritis",
            "Fractures, Stress"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "This long term follow-up study is performed to assess the long-term safety and efficacy of CARTISTEM\u00ae, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture. Subjects, who were either administered CARTISTEM or treated with conventional microfracture in the primary phase III study (NCT01041001), will be further observed using various subjective knee assessments and MRI T2 mapping until the 60 month post-treatment timepoint."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nPatients with knee joint cartilage defect or injury of ICRS (International Cartilage Repair Society) Grade 4 confirmed by arthroscopy (At screening, patients diagnosed as such with an MRI may be included)\nMale or female patients at least 18 years of age\nPatients whose lesion (unilateral joint) is 2 \u33a0 ~ 9\u33a0 in size\nPatients with articular swelling, tenderness and active range of motion of Grade 2 or below\nPatients with pain in affected joint of 60-mm or below on a 100-mm VAS (visual analogue scale)\nPatients with adequate blood coagulation activity: PT(INR) < 1.5, APTT <1.5\u00d7control\nPatients with adequate renal function: Creatinine \u2264 2.0 \u338e/\u3397, levels of proteinuria measured with Dipstick: trace or less\nPatients with adequate hepatic function: Bilirubin \u2264 2.0 \u338e/\u3397, AST/ALT \u2264 100 IU/L\nPatients who have received no surgery or radiation therapy in the affected joint within the past 6 six weeks, and have recovered from the side effects of such past treatments\nFemale patients of childbearing potential must agree to practice adequate methods of birth control to prevent pregnancy during the study\nPatients whose physical examination results show no ligament instability of Grade II or above (Grade 0: none, Grade I: 0-5 mm, Grade II: 5-10 mm, Grade III: >10 mm)\nPatients who voluntarily agreed to enroll in the study and signed an informed consent form\n\nExclusion Criteria:\n\nPatients with autoimmune disease or the medical history\nPatients with infections requiring parenteral administration of antibiotics\nPatients with myocardial infarction, ischemic heart failure, other serious heart conditions or uncontrolled hypertension, or any medical history of such diseases\nPatients with serious internal diseases\nPatients who are currently pregnant or nursing\nPatients with psychotic diseases, epilepsy, or any history of such diseases\nPatients with alcohol abuse\nPatients who smoke excessively\nPatients with chronic inflammatory articular diseases such as rheumatoid arthritis\nPatients who were enrolled in any other clinical trials within the past four weeks\nPatients who had been administered with immunosuppressants such as Cyclosporin A or azathioprine within the past six weeks\nPatients whose physical examination results show ligament instability of Grade II or above (Grade 0: none, Grade I: 0-5 mm, Grade II: 5-10 mm, Grade III: >10 mm)\nPatients with a known history of hypersensitivity/allergy to gentamicin\nPatients whom the principal investigator considers inappropriate for the clinical trial due to any other reasons than those listed above"
      ],
      "EnrollmentCount": [
            "103"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "Undecided"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "CARTISTEM",
            "Microfracture"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "A single dose of 500\u3395/\u33a0 of cartilage defect",
            "Active control"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "CARTISTEM",
            "Microfracture"
      ],
      "InterventionOtherName": [
            "hUCB-MSCs",
            "Conventional surgical treatment"
      ],
      "InterventionType": [
            "Biological",
            "Procedure"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Umbilical Cord Blood",
            "Mesenchymal Stem Cells",
            "Cartilage injury",
            "Osteoarthritis"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "April 20, 2017"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "April 19, 2017"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Medipost Co Ltd."
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Incheon",
            "Incheon",
            "Seoul",
            "Seoul",
            "Seoul",
            "Seoul",
            "Seoul",
            "Seoul",
            "Seoul",
            "Seoul"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of"
      ],
      "LocationFacility": [
            "Inha University Hospital",
            "Gachon University Gil Hospital",
            "Kangbuk Samsung Hospital",
            "Hanyang University Medical Center",
            "Seoul Veterans Hospital",
            "Samsung Medical Center",
            "Gangnam Severance Hospital",
            "Asan Medical Center",
            "Korea University Guro Hospital",
            "Ewha Womans University Mokdong Hospital"
      ],
      "LocationState": [],
      "LocationStatus": [],
      "LocationZip": [
            "400-711",
            "405-760",
            "110-746",
            "133-792",
            "134-060",
            "135-710",
            "135-720",
            "138-736",
            "152-703",
            "158-710"
      ],
      "MaximumAge": [],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [
            "NCT01923532"
      ],
      "OfficialTitle": [
            "Long Term Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Medipost Co Ltd."
      ],
      "OrgStudyId": [
            "CARTISTEM_CR_F/U"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Korea University Guro Hospital",
            "Gachon University Gil Medical Center",
            "Gangnam Severance Hospital",
            "Kangbuk Samsung Hospital",
            "Samsung Medical Center",
            "Seoul Veterans Hospital",
            "Asan Medical Center",
            "Ewha Womans Mokdong Hospital",
            "Inha University Hospital",
            "Hanyang University",
            "Samsung Medical Center"
      ],
      "OverallOfficialName": [
            "Hong-chul Lim, MD, PhD",
            "Beom-gu Lee, MD, PhD",
            "Jong-hyeok Choi, MD, PhD",
            "Hwa-jae Jeong, MD, PhD",
            "Chul-won Ha, MD, PhD",
            "Jung-ro Yoon, MD, PhD",
            "Seong-il Bin, MD, PhD",
            "Jae-doo Yoo, MD, PhD",
            "Myung-ku Kim, MD, PhD",
            "Choong-hyuk Choi, MD, PhD",
            "Young-Chul Yoon, MD, PhD"
      ],
      "OverallOfficialRole": [
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Completed"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 3"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "May 2015"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [
            "Knee assessments will be performed using the following tools:\n\nIKDC (International Knee Documentation Committee)\nPain score on VAS (Visual Analogue Scale)\nWOMAC (Western Ontario and McMaster Universities Arthritis Index)"
      ],
      "PrimaryOutcomeMeasure": [
            "Degree of improvement in knee assessments compared to the active control (microfracture)"
      ],
      "PrimaryOutcomeTimeFrame": [
            "36 months, 48 months, and 60 months"
      ],
      "ReferenceCitation": [
            "Lim HC, Park YB, Ha CW, Cole BJ, Lee BK, Jeong HJ, Kim MK, Bin SI, Choi CH, Choi CH, Yoo JD; Cartistem Research Group, Yoon JR, Chung JY. Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up. Orthop J Sports Med. 2021 Jan 12;9(1):2325967120973052. doi: 10.1177/2325967120973052. eCollection 2021 Jan."
      ],
      "ReferencePMID": [
            "33490296"
      ],
      "ReferenceType": [
            "derived"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Systemic and local adverse events especially attributable to the implanted cells will be assessed.\n\nGeneral physical examinations: vital signs, blood tests\nPhysical assessments of the knee: swelling, tenderness, pain, range of motion\nTumor formation at the implantation site: radiological evaluation using MRI(T1(dGEMRIC)and T2 mapping)"
      ],
      "SecondaryOutcomeMeasure": [
            "Number of subjects with adverse events"
      ],
      "SecondaryOutcomeTimeFrame": [
            "36 months, 48 months, and 60 months"
      ],
      "SeeAlsoLinkLabel": [
            "Study to Compare the Efficacy and Safety of Cartistem\u00ae and Microfracture in Patients With Knee Articular Cartilage Injury or Defect"
      ],
      "SeeAlsoLinkURL": [
            "http://clinicaltrials.gov/ct2/show/NCT01041001?term=cartistem&rank=1"
      ],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "June 2012"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "April 2017"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "June 25, 2012"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "June 19, 2012"
      ],
      "StudyFirstSubmitQCDate": [
            "June 20, 2012"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}